Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesar Moran

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Oncotarget|March 28, 2018
Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancerDaniel Richard Gomez, Lauren Averett Byers, Monique Nilsson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2018
Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung CancerYang Xie, Wei Lu, Shidan Wang, et al.
Clinical Lung Cancer|August 9, 2020
Female Gender Predicts Augmented Immune Infiltration in Lung AdenocarcinomaCarmen Behrens, Pedro Rocha, Edwin R Parra, et al.
Journal of the National Cancer Institute|February 25, 2014
Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancerHumam Kadara, Junya Fujimoto, Suk-Young Yoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma PatientsEdwin R Parra, Carmen Behrens, Jaime Rodriguez-Canales, et al.
Journal for Immunotherapy of Cancer|June 7, 2018
Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approachesEdwin R Parra, Pamela Villalobos, Carmen Behrens, et al.
The American Journal of Surgical Pathology|February 2, 2010
Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data setDavid S Klimstra, Irvin R Modlin, N Volkan Adsay, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2019
Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung CancerHumam Kadara, Smruthy Sivakumar, Yasminka Jakubek, et al.
Cancer Innovation|July 1, 2024
Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomesSahil Seth, Runzhe Chen, Yang Liu, et al.
Nature Cancer|February 1, 2021
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancerC Allison Stewart, Carl M Gay, Yuanxin Xi, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Oncotarget|March 28, 2018
Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancerDaniel Richard Gomez, Lauren Averett Byers, Monique Nilsson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2018
Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung CancerYang Xie, Wei Lu, Shidan Wang, et al.
Clinical Lung Cancer|August 9, 2020
Female Gender Predicts Augmented Immune Infiltration in Lung AdenocarcinomaCarmen Behrens, Pedro Rocha, Edwin R Parra, et al.
Journal of the National Cancer Institute|February 25, 2014
Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancerHumam Kadara, Junya Fujimoto, Suk-Young Yoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma PatientsEdwin R Parra, Carmen Behrens, Jaime Rodriguez-Canales, et al.
Journal for Immunotherapy of Cancer|June 7, 2018
Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approachesEdwin R Parra, Pamela Villalobos, Carmen Behrens, et al.
The American Journal of Surgical Pathology|February 2, 2010
Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data setDavid S Klimstra, Irvin R Modlin, N Volkan Adsay, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2019
Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung CancerHumam Kadara, Smruthy Sivakumar, Yasminka Jakubek, et al.
Cancer Innovation|July 1, 2024
Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomesSahil Seth, Runzhe Chen, Yang Liu, et al.
Nature Cancer|February 1, 2021
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancerC Allison Stewart, Carl M Gay, Yuanxin Xi, et al.
Pageof 8